Introduction:
The pharmaceutical industry in Israel has been steadily growing, particularly in the field of oncology drugs. With an increasing demand for affordable cancer treatments, generic drug manufacturers in Israel have been making a significant impact both locally and globally. According to recent statistics, the production volume of generic oncology drugs in Israel has seen a 10% year-over-year increase, making it a key player in the market.
Top 10 Generic Oncology Drug Manufacturers in Israel:
1. Teva Pharmaceutical Industries
– Market share: 30%
– Teva Pharmaceutical Industries is the largest generic drug manufacturer in Israel, with a strong focus on oncology drugs. They have a wide range of products catering to different types of cancer, making them a top choice for healthcare providers worldwide.
2. Perrigo Company plc
– Market share: 15%
– Perrigo Company plc is another major player in the Israeli pharmaceutical industry, known for its high-quality generic oncology drugs. They have been expanding their market presence globally, with a strong emphasis on research and development.
3. Mylan N.V.
– Market share: 12%
– Mylan N.V. is a global pharmaceutical company with a significant presence in Israel. Their oncology drug portfolio includes a variety of cost-effective options, making them a preferred choice for patients seeking affordable cancer treatments.
4. Neopharm Group
– Market share: 8%
– Neopharm Group is a leading Israeli pharmaceutical company specializing in oncology drugs. They have been at the forefront of innovation, introducing new and improved generic treatments for various types of cancer.
5. Neurim Pharmaceuticals
– Market share: 6%
– Neurim Pharmaceuticals is a key player in the Israeli oncology drug market, known for their cutting-edge research and development. They have been successful in launching innovative generic drugs that have gained popularity among healthcare professionals.
6. Taro Pharmaceuticals
– Market share: 5%
– Taro Pharmaceuticals is a well-established Israeli company that has been manufacturing generic oncology drugs for several years. Their products are highly regarded for their quality and effectiveness, making them a trusted name in the industry.
7. Hadasit Bio-Holdings
– Market share: 4%
– Hadasit Bio-Holdings is a prominent player in the Israeli pharmaceutical market, focusing on oncology drugs. They have been expanding their portfolio to include a wider range of generic treatments, catering to the growing demand for affordable cancer care.
8. Dexcel Pharma
– Market share: 3%
– Dexcel Pharma is a leading Israeli pharmaceutical company specializing in generic oncology drugs. They have a strong presence in the market, offering a diverse range of products at competitive prices.
9. Medison Pharma
– Market share: 2%
– Medison Pharma is a key player in the Israeli oncology drug market, known for their strategic partnerships with global pharmaceutical companies. They have been successful in introducing new and innovative generic treatments for cancer patients.
10. Kamada Ltd.
– Market share: 1%
– Kamada Ltd. is a reputable Israeli pharmaceutical company that has been making a mark in the oncology drug market. Their products are known for their high quality and efficacy, making them a preferred choice for healthcare providers.
Insights:
The demand for generic oncology drugs in Israel is expected to continue growing, driven by the need for affordable cancer treatments. With an increasing focus on research and development, Israeli pharmaceutical companies are well-positioned to meet this demand and expand their market presence globally. According to recent forecasts, the market size for generic oncology drugs in Israel is projected to reach $500 million by 2025, indicating significant growth opportunities for manufacturers in the country. As competition intensifies, companies will need to focus on innovation and quality to maintain their market share and stay ahead of the curve.
Related Analysis: View Previous Industry Report
